10
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

10
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transforming Growth Factor Beta 1 Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-12A244
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Transforming Growth Factor Beta 1 Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Transforming Growth Factor Beta 1 Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-12A244
Report
July 2025
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Transforming Growth Factor Beta 1 Market Size

In 2024, the global market size of Transforming Growth Factor Beta 1 was estimated to be worth US$ 1797 million and is forecast to reach approximately US$ 3717 million by 2031 with a CAGR of 11.1% during the forecast period 2025-2031.

Transforming Growth Factor Beta 1 Market

Transforming Growth Factor Beta 1 Market

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transforming Growth Factor Beta 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transforming Growth Factor Beta 1.
The Transforming Growth Factor Beta 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transforming Growth Factor Beta 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transforming Growth Factor Beta 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Transforming Growth Factor Beta 1 Market Report

Report Metric Details
Report Name Transforming Growth Factor Beta 1 Market
Forecasted market size in 2031 approximately US$ 3717 million
CAGR 11.1%
Forecasted years 2025 - 2031
Segment by Type
  • Pirfenidone
  • Galunisertib
  • Others
Segment by Application
  • IPF
  • Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Transforming Growth Factor Beta 1 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transforming Growth Factor Beta 1 sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Transforming Growth Factor Beta 1 Market size in 2031?

Ans: The Transforming Growth Factor Beta 1 Market size in 2031 will be approximately US$ 3717 million.

What is the Transforming Growth Factor Beta 1 Market share by region?

Ans: In humans, TGF-β1 is encoded by the TGFB1 gene North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.

Who are the main players in the Transforming Growth Factor Beta 1 Market report?

Ans: The main players in the Transforming Growth Factor Beta 1 Market are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG

What are the Application segmentation covered in the Transforming Growth Factor Beta 1 Market report?

Ans: The Applications covered in the Transforming Growth Factor Beta 1 Market report are IPF, Cancer, Others

What are the Type segmentation covered in the Transforming Growth Factor Beta 1 Market report?

Ans: The Types covered in the Transforming Growth Factor Beta 1 Market report are Pirfenidone, Galunisertib, Others

1 Study Coverage
1.1 Transforming Growth Factor Beta 1 Product Introduction
1.2 Market by Type
1.2.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
1.3 Market by Application
1.3.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 IPF
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts
2.1.1 Global Transforming Growth Factor Beta 1 Revenue 2020-2031
2.1.2 Global Transforming Growth Factor Beta 1 Sales 2020-2031
2.2 Transforming Growth Factor Beta 1 Market Size by Region: 2024 Versus 2031
2.3 Transforming Growth Factor Beta 1 Sales by Region (2020-2031)
2.3.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2020-2025
2.3.2 Global Transforming Growth Factor Beta 1 Sales Forecast by Region (2026-2031)
2.3.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2020-2031)
2.4 Transforming Growth Factor Beta 1 Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2020-2025
2.4.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Region (2026-2031)
2.4.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Transforming Growth Factor Beta 1 Sales by Type (2020-2031)
3.1.1.1 Global Transforming Growth Factor Beta 1 Sales Volume by Type (2020-2031)
3.1.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2031)
3.1.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2020-2031)
3.1.2.1 Global Transforming Growth Factor Beta 1 Revenue by Type (2020-2031)
3.1.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2020-2031)
3.1.3 Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Transforming Growth Factor Beta 1 Sales by Application (2020-2031)
3.2.1.1 Global Transforming Growth Factor Beta 1 Sales Volume by Application (2020-2031)
3.2.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2031)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2020-2031)
3.2.2.1 Global Transforming Growth Factor Beta 1 Revenue by Application (2020-2031)
3.2.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2020-2031)
3.2.3 Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Pirfenidone of Transforming Growth Factor Beta 1 Revenue Market Share by Application
3.3.2 Galunisertib of Transforming Growth Factor Beta 1 Revenue Market Share by Application
3.3.3 Others of Transforming Growth Factor Beta 1 Revenue Market Share by Application
4 Global Transforming Growth Factor Beta 1 by Manufacturers
4.1 Global Top Transforming Growth Factor Beta 1 Manufacturers by Sales (2020-2025)
4.1.1 Global Transforming Growth Factor Beta 1 Sales by Manufacturer (2020-2025)
4.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Transforming Growth Factor Beta 1 Manufacturers by Revenue (2020-2025)
4.2.1 Global Transforming Growth Factor Beta 1 Revenue by Manufacturer (2020-2025)
4.2.2 Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturer (2020-2025)
4.3 Global Transforming Growth Factor Beta 1 Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Transforming Growth Factor Beta 1 Manufacturers Covered: Ranking by Revenue
4.4.2 Global Transforming Growth Factor Beta 1 Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Transforming Growth Factor Beta 1 Manufacturing Base Distribution, Product Type
4.5.1 Transforming Growth Factor Beta 1 Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Transforming Growth Factor Beta 1 Market
4.5.3 Manufacturers Transforming Growth Factor Beta 1 Product Type and Application
4.5.4 Pirfenidone Market Sales of Transforming Growth Factor Beta 1 by Manufacturer
4.5.5 Galunisertib Market Sales of Transforming Growth Factor Beta 1 by Manufacturer
4.5.6 Others Market Sales of Transforming Growth Factor Beta 1 by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Company Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche Transforming Growth Factor Beta 1 Products Offered
5.1.4 Roche Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Roche Transforming Growth Factor Beta 1 Sales by Product in 2024
5.1.6 Roche Transforming Growth Factor Beta 1 Sales by Application in 2024
5.1.7 Roche Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Shionogi Ltd
5.2.1 Shionogi Ltd Company Information
5.2.2 Shionogi Ltd Description, Business Overview
5.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Products Offered
5.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Shionogi Ltd Transforming Growth Factor Beta 1 Sales by Product in 2024
5.2.6 Shionogi Ltd Transforming Growth Factor Beta 1 Sales by Application in 2024
5.2.7 Shionogi Ltd Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.2.8 Shionogi Ltd Recent Developments
5.3 Acceleron Pharma Inc
5.3.1 Acceleron Pharma Inc Company Information
5.3.2 Acceleron Pharma Inc Description, Business Overview
5.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Products Offered
5.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales by Product in 2024
5.3.6 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales by Application in 2024
5.3.7 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.3.8 Acceleron Pharma Inc Recent Developments
5.4 Genzyme Corp
5.4.1 Genzyme Corp Company Information
5.4.2 Genzyme Corp Description, Business Overview
5.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Products Offered
5.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Genzyme Corp Transforming Growth Factor Beta 1 Sales by Product in 2024
5.4.6 Genzyme Corp Transforming Growth Factor Beta 1 Sales by Application in 2024
5.4.7 Genzyme Corp Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.4.8 Genzyme Corp Recent Developments
5.5 Isarna Therapeutics GmbH
5.5.1 Isarna Therapeutics GmbH Company Information
5.5.2 Isarna Therapeutics GmbH Description, Business Overview
5.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Products Offered
5.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales by Product in 2024
5.5.6 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales by Application in 2024
5.5.7 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.5.8 Isarna Therapeutics GmbH Recent Developments
5.6 Scholar Rock
5.6.1 Scholar Rock Company Information
5.6.2 Scholar Rock Description, Business Overview
5.6.3 Scholar Rock Transforming Growth Factor Beta 1 Products Offered
5.6.4 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Scholar Rock Transforming Growth Factor Beta 1 Sales by Product in 2024
5.6.6 Scholar Rock Transforming Growth Factor Beta 1 Sales by Application in 2024
5.6.7 Scholar Rock Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.6.8 Scholar Rock Recent Developments
5.7 Sirnaomics Inc
5.7.1 Sirnaomics Inc Company Information
5.7.2 Sirnaomics Inc Description, Business Overview
5.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Products Offered
5.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales by Product in 2024
5.7.6 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales by Application in 2024
5.7.7 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.7.8 Sirnaomics Inc Recent Developments
5.8 Eli Lilly and Co
5.8.1 Eli Lilly and Co Company Information
5.8.2 Eli Lilly and Co Description, Business Overview
5.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Products Offered
5.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales by Product in 2024
5.8.6 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales by Application in 2024
5.8.7 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.8.8 Eli Lilly and Co Recent Developments
5.9 Formation Biologics Inc
5.9.1 Formation Biologics Inc Company Information
5.9.2 Formation Biologics Inc Description, Business Overview
5.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Products Offered
5.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales by Product in 2024
5.9.6 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales by Application in 2024
5.9.7 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.9.8 Formation Biologics Inc Recent Developments
5.10 Novartis AG
5.10.1 Novartis AG Company Information
5.10.2 Novartis AG Description, Business Overview
5.10.3 Novartis AG Transforming Growth Factor Beta 1 Products Offered
5.10.4 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Novartis AG Transforming Growth Factor Beta 1 Sales by Product in 2024
5.10.6 Novartis AG Transforming Growth Factor Beta 1 Sales by Application in 2024
5.10.7 Novartis AG Transforming Growth Factor Beta 1 Sales by Geographic Area in 2024
5.10.8 Novartis AG Recent Developments
6 North America
6.1 North America Transforming Growth Factor Beta 1 Market Size YoY Growth 2020-2031
6.2 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
6.2.1 North America Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
6.2.2 North America Transforming Growth Factor Beta 1 Revenue by Country (2020-2031)
6.3 North America Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
6.4 North America Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Transforming Growth Factor Beta 1 Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Region
7.2.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Region (2020-2031)
7.2.2 Asia-Pacific Transforming Growth Factor Beta 1 Revenue by Region (2020-2031)
7.3 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
7.4 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
8 Europe
8.1 Europe Transforming Growth Factor Beta 1 Market Size YoY Growth 2020-2031
8.2 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Country
8.2.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
8.2.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2020-2031)
8.3 Europe Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
8.4 Europe Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Transforming Growth Factor Beta 1 Market Size YoY Growth 2020-2031
9.2 Latin America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
9.2.1 Latin America Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
9.2.2 Latin America Transforming Growth Factor Beta 1 Revenue by Country (2020-2031)
9.3 Latin America Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
9.4 Latin America Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Transforming Growth Factor Beta 1 Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Country
10.2.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
10.2.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2020-2031)
10.3 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
10.4 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Transforming Growth Factor Beta 1 Supply Chain Analysis
11.2 Transforming Growth Factor Beta 1 Key Raw Materials and Upstream Suppliers
11.3 Transforming Growth Factor Beta 1 Clients Analysis
11.4 Transforming Growth Factor Beta 1 Sales Channel and Sales Model Analysis
11.4.1 Transforming Growth Factor Beta 1 Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Transforming Growth Factor Beta 1 Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Transforming Growth Factor Beta 1 Distributors
12 Transforming Growth Factor Beta 1 Market Dynamics
12.1 Transforming Growth Factor Beta 1 Industry Trends
12.2 Transforming Growth Factor Beta 1 Market Drivers
12.3 Transforming Growth Factor Beta 1 Market Challenges
12.4 Transforming Growth Factor Beta 1 Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Transforming Growth Factor Beta 1 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Transforming Growth Factor Beta 1 Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Transforming Growth Factor Beta 1 Sales by Region (2020-2025) & (K Units)
 Table 5. Global Transforming Growth Factor Beta 1 Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Transforming Growth Factor Beta 1 Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Transforming Growth Factor Beta 1 Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Transforming Growth Factor Beta 1 Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Transforming Growth Factor Beta 1 Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Transforming Growth Factor Beta 1 Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Transforming Growth Factor Beta 1 Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Transforming Growth Factor Beta 1 Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Transforming Growth Factor Beta 1 Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Transforming Growth Factor Beta 1 Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Transforming Growth Factor Beta 1 Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Transforming Growth Factor Beta 1 Sales Share by Manufacturer (2020-2025)
 Table 18. Transforming Growth Factor Beta 1 Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Transforming Growth Factor Beta 1 Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Transforming Growth Factor Beta 1 Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Transforming Growth Factor Beta 1 Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Transforming Growth Factor Beta 1 Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Transforming Growth Factor Beta 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transforming Growth Factor Beta 1 as of 2024)
 Table 24. Transforming Growth Factor Beta 1 Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Transforming Growth Factor Beta 1 Market
 Table 26. Manufacturers Transforming Growth Factor Beta 1 Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Roche Company Information
 Table 29. Roche Description and Business Overview
 Table 30. Roche Transforming Growth Factor Beta 1 Product
 Table 31. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Roche Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 33. Roche Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 34. Roche Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 35. Roche Recent Developments
 Table 36. Shionogi Ltd Company Information
 Table 37. Shionogi Ltd Description and Business Overview
 Table 38. Shionogi Ltd Transforming Growth Factor Beta 1 Product
 Table 39. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Shionogi Ltd Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 41. Shionogi Ltd Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 42. Shionogi Ltd Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 43. Shionogi Ltd Recent Developments
 Table 44. Acceleron Pharma Inc Company Information
 Table 45. Acceleron Pharma Inc Description and Business Overview
 Table 46. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product
 Table 47. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Acceleron Pharma Inc Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 49. Acceleron Pharma Inc Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 50. Acceleron Pharma Inc Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 51. Acceleron Pharma Inc Recent Developments
 Table 52. Genzyme Corp Company Information
 Table 53. Genzyme Corp Description and Business Overview
 Table 54. Genzyme Corp Transforming Growth Factor Beta 1 Product
 Table 55. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Genzyme Corp Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 57. Genzyme Corp Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 58. Genzyme Corp Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 59. Genzyme Corp Recent Developments
 Table 60. Isarna Therapeutics GmbH Company Information
 Table 61. Isarna Therapeutics GmbH Description and Business Overview
 Table 62. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product
 Table 63. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Isarna Therapeutics GmbH Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 65. Isarna Therapeutics GmbH Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 66. Isarna Therapeutics GmbH Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 67. Isarna Therapeutics GmbH Recent Developments
 Table 68. Scholar Rock Company Information
 Table 69. Scholar Rock Description and Business Overview
 Table 70. Scholar Rock Transforming Growth Factor Beta 1 Product
 Table 71. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Scholar Rock Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 73. Scholar Rock Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 74. Scholar Rock Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 75. Scholar Rock Recent Developments
 Table 76. Sirnaomics Inc Company Information
 Table 77. Sirnaomics Inc Description and Business Overview
 Table 78. Sirnaomics Inc Transforming Growth Factor Beta 1 Product
 Table 79. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Sirnaomics Inc Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 81. Sirnaomics Inc Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 82. Sirnaomics Inc Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 83. Sirnaomics Inc Recent Developments
 Table 84. Eli Lilly and Co Company Information
 Table 85. Eli Lilly and Co Description and Business Overview
 Table 86. Eli Lilly and Co Transforming Growth Factor Beta 1 Product
 Table 87. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Eli Lilly and Co Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 89. Eli Lilly and Co Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 90. Eli Lilly and Co Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 91. Eli Lilly and Co Recent Developments
 Table 92. Formation Biologics Inc Company Information
 Table 93. Formation Biologics Inc Description and Business Overview
 Table 94. Formation Biologics Inc Transforming Growth Factor Beta 1 Product
 Table 95. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Formation Biologics Inc Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 97. Formation Biologics Inc Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 98. Formation Biologics Inc Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 99. Formation Biologics Inc Recent Developments
 Table 100. Novartis AG Company Information
 Table 101. Novartis AG Description and Business Overview
 Table 102. Novartis AG Transforming Growth Factor Beta 1 Product
 Table 103. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Novartis AG Sales Proportion of Transforming Growth Factor Beta 1 by Product in 2024
 Table 105. Novartis AG Sales Proportion of Transforming Growth Factor Beta 1 by Application in 2024
 Table 106. Novartis AG Sales Proportion of Transforming Growth Factor Beta 1 by Geographic Area in 2024
 Table 107. Novartis AG Recent Developments
 Table 108. North America Transforming Growth Factor Beta 1 Sales by Country (2020-2025) & (K Units)
 Table 109. North America Transforming Growth Factor Beta 1 Sales by Country (2026-2031) & (K Units)
 Table 110. North America Transforming Growth Factor Beta 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 111. North America Transforming Growth Factor Beta 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 112. North America Transforming Growth Factor Beta 1 Sales by Type (2020-2025) & (K Units)
 Table 113. North America Transforming Growth Factor Beta 1 Sales by Application (2020-2025) & (K Units)
 Table 114. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Region (2020-2025) & (K Units)
 Table 115. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Region (2026-2031) & (K Units)
 Table 116. Asia-Pacific Transforming Growth Factor Beta 1 Revenue by Region (2020-2025) & (US$ Million)
 Table 117. Asia-Pacific Transforming Growth Factor Beta 1 Revenue by Region (2026-2031) & (US$ Million)
 Table 118. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Type (2020-2025) & (K Units)
 Table 119. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Application (2020-2025) & (K Units)
 Table 120. Europe Transforming Growth Factor Beta 1 Sales by Country (2020-2025) & (K Units)
 Table 121. Europe Transforming Growth Factor Beta 1 Sales by Country (2026-2031) & (K Units)
 Table 122. Europe Transforming Growth Factor Beta 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 123. Europe Transforming Growth Factor Beta 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 124. Europe Transforming Growth Factor Beta 1 Sales by Type (2020-2025) & (K Units)
 Table 125. Europe Transforming Growth Factor Beta 1 Sales by Application (2020-2025) & (K Units)
 Table 126. Latin America Transforming Growth Factor Beta 1 Sales by Country (2020-2025) & (K Units)
 Table 127. Latin America Transforming Growth Factor Beta 1 Sales by Country (2026-2031) & (K Units)
 Table 128. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 129. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 130. Latin America Transforming Growth Factor Beta 1 Sales by Type (2020-2025) & (K Units)
 Table 131. Latin America Transforming Growth Factor Beta 1 Sales by Application (2020-2025) & (K Units)
 Table 132. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2020-2025) & (K Units)
 Table 133. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2026-2031) & (K Units)
 Table 134. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 135. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 136. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2020-2025) & (K Units)
 Table 137. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2020-2025) & (K Units)
 Table 138. Transforming Growth Factor Beta 1 Key Raw Materials, Industry Status and Trend
 Table 139. Transforming Growth Factor Beta 1 Key Raw Materials and Upstream Suppliers
 Table 140. Transforming Growth Factor Beta 1 Clients Status and Trend
 Table 141. Transforming Growth Factor Beta 1 Typical Clients
 Table 142. Transforming Growth Factor Beta 1 Distributors
 Table 143. Transforming Growth Factor Beta 1 Market Trends
 Table 144. Transforming Growth Factor Beta 1 Market Drivers
 Table 145. Transforming Growth Factor Beta 1 Market Challenges
 Table 146. Transforming Growth Factor Beta 1 Market Restraints
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Transforming Growth Factor Beta 1 Product Picture
 Figure 2. Global Transforming Growth Factor Beta 1 Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2024 & 2031
 Figure 4. Pirfenidone Product Picture
 Figure 5. Galunisertib Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Transforming Growth Factor Beta 1 Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Transforming Growth Factor Beta 1 Sales Market Share by Application in 2024 & 2031
 Figure 9. IPF
 Figure 10. Cancer
 Figure 11. Others
 Figure 12. Transforming Growth Factor Beta 1 Report Years Considered
 Figure 13. Global Transforming Growth Factor Beta 1 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Transforming Growth Factor Beta 1 Market Size 2020-2031 (US$ Million)
 Figure 15. Global Transforming Growth Factor Beta 1 Sales 2020-2031 (K Units)
 Figure 16. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2020-2031)
 Figure 18. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 21. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 24. Pirfenidone of Transforming Growth Factor Beta 1 Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Galunisertib of Transforming Growth Factor Beta 1 Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Others of Transforming Growth Factor Beta 1 Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Global Transforming Growth Factor Beta 1 Sales Share by Manufacturer in 2024
 Figure 28. Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Pirfenidone Market Sales Proportion by Manufacturer in 2024
 Figure 30. Galunisertib Market Sales Proportion by Manufacturer in 2024
 Figure 31. Others Market Sales Proportion by Manufacturer in 2024
 Figure 32. North America Transforming Growth Factor Beta 1 Revenue 2020-2031 (US$ Million)
 Figure 33. North America Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2025)
 Figure 34. North America Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2025)
 Figure 35. Asia-Pacific Transforming Growth Factor Beta 1 Revenue 2020-2031 (US$ Million)
 Figure 36. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share by Region (2020-2031)
 Figure 37. Asia-Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2025)
 Figure 39. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2025)
 Figure 40. Europe Transforming Growth Factor Beta 1 Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2020-2031)
 Figure 42. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2020-2031)
 Figure 43. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2025)
 Figure 44. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2025)
 Figure 45. Latin America Transforming Growth Factor Beta 1 Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2020-2025)
 Figure 48. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2025)
 Figure 49. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2025)
 Figure 50. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2025)
 Figure 54. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2025)
 Figure 55. Transforming Growth Factor Beta 1 Supply Chain (Upstream and Downstream Market)
 Figure 56. Global Production Market Share of Transforming Growth Factor Beta 1 Raw Materials by Region in 2024
 Figure 57. Transforming Growth Factor Beta 1 Distribution Channels
 Figure 58. Global Transforming Growth Factor Beta 1 Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 59. Global Transforming Growth Factor Beta 1 Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD